Viewing data from:

IMIPRAMINE HYDROCHLORIDE

ANDA

IMIPRAMINE HYDROCHLORIDE | A040903 | LEADING PHARMA LLC

3 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 6 NDCs

Highest NADAC/Unit

$0.1536

per ea

Lowest NADAC/Unit

$0.0657

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
69315013501IMIPRAMINE HCL 50 MG TABLET	$0.1536	EA	Generic	—	2026-08-19
69315013510IMIPRAMINE HCL 50 MG TABLET	$0.1536	EA	Generic	—	2026-08-19
69315013401IMIPRAMINE HCL 25 MG TABLET	$0.0912	EA	Generic	—	2026-08-19
69315013410IMIPRAMINE HCL 25 MG TABLET	$0.0912	EA	Generic	—	2026-08-19
69315013301IMIPRAMINE HCL 10 MG TABLET	$0.0657	EA	Generic	—	2026-08-19
69315013310IMIPRAMINE HCL 10 MG TABLET	$0.0657	EA	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 3 NDCs (3 FSS)

Lowest Price

$4.40

Highest Price

$7.06

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
72789-0492-01IMIPRAMINE HCL 25MG TAB	$4.40	FSS	PD-Rx Pharmaceuticals, Inc.	05/31/2026
72789-0493-01IMIPRAMINE HCL 50MG TAB	$5.30	FSS	PD-Rx Pharmaceuticals, Inc.	05/31/2026
69315-0133-01IMIPRAMINE HCL 10MG TAB	$7.06	FSS	AvKare, LLC	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain2 active DMFs8 inactive

2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

TAPI NL BVIMIPRAMINE HYDROCHLORIDE USP

DMF 19061972

LUPIN LTDIMIPRAMINE HYDROCHLORIDE USP

DMF 214382008

LUNDBECK PHARMACEUTICALS ITALY SPAInactiveIMIPRAMINE HYDROCHLORIDE

DMF 19131972

DELMAR CHEMICALS INCInactiveIMIPRAMINE HYDROCHLORIDE

DMF 21191973

IROPHARM LTDInactiveIMIPRAMINE HYDROCHLORIDE

DMF 65351986

ACF CHEMIEFARMA NVInactiveIMIPRAMINE HYDROCHLORIDE

DMF 67641987

SELOC AGInactiveIMIPRAMINE HYDROCHLORIDE

DMF 68061987

ARCHIMICA SPAInactiveIMIPRAMINE HYDROCHLORIDE

DMF 71901987

EGIS PHARMACEUTICALS PRIVATE LTDInactiveIMIPRAMINE HYDROCHLORIDE

DMF 79461989

SUN PHARMACEUTICAL INDUSTRIES LTDInactiveIMIPRAMINE HYDROCHLORIDE USP

DMF 202982007

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 10MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Oct 24, 2012

No patent or exclusivity listings for this strength.

#002 — 25MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Oct 24, 2012

#003 — 50MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Oct 24, 2012